3.80Open3.80Pre Close0 Volume4 Open Interest22.50Strike Price0.00Turnover0.00%IV-2.02%PremiumJan 17, 2025Expiry Date4.17Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.61Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet